Treatment of canine atopic dermatitis with misoprostol, a prostaglandin E1 analogue: An open study

Journal of Dermatological Treatment

Volumn 8, Issue 4, 1997, Pages 243-247

  Olivry, T ^a   Guaguere E ^b   Heripret D ^c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b CLINIQUE VÉTÉRINAIRE   (France)

^c CENTRE HOSPITALIER VÉTÉRINAIRE FRÉGIS   (France)

Author keywords

Atopic dermatitis; Canine; Misoprostol; Prostaglandin E

Indexed keywords

MISOPROSTOL;

ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DIARRHEA; DOG DISEASE; NONHUMAN; PRIORITY JOURNAL; PRURITUS; TOPICAL DRUG ADMINISTRATION; VOMITING;

EID: 0031437629     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639709160529     Document Type: Article

References (34)

1. Frank LA, Atopic dermatitis. Clin Dermatol (1994) 12: 565-71.
2. Chalmers SA, Medleau L, An update on atopic dermatitis in dogs. Vet Med US (1994) 89: 326-41
3. White SD, Bourdeau P, L'atopie chez le chien: données actualisée (Atopy in the dog: an update). Point Vet (1995) 27: 11-21.
4. Becker AB et al, Cutaneous allergic response in atopic dogs: relationship of cellular and histamine response. J Allergy Clin Immunol (1988) 81: 441-8.
5. Thomsen MK, Kristensen F, Filing F, Species specificity in the generation of eicosanoids: emphasis on leukocyte-activating factors in the skin of allergic dogs and humans. In: Ihrke PJ, Mason IS, White SD (eds) Advances in veterinary dermatology, vol 2. Pergamon Press: Oxford, 1993, pp 63-78
6. Olivry T, Mécanismes pathogéniques de la dermite atopique canine (Pathogenic mechanisms of canine atopic dermatitis). Officiel Dermatol (1995) 49: 37-40.
7. Shields MJ, Novel application of misoprostol. Pharmacol Ther (1995) 65: 125-47.
8. Mahatma M et al, Misoprostol, but not antacid, prevents endotoxin-induced gastric mucosal injury: role of tumor necrosis factor alpha. Dig Dis Sci (1991) 36: 1562-8.
9. Haynes DR, Whitehouse MW, Vernon-Roberts B, The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology (1992) 76: 251-7.
10. Nakamura C et al, Contrasting effects of misoprostol on systemic and intrapulmonary lipopolysaccharide-induced tumor necrosis factor-alpha. Life Sci (1992) 50: 1869-76.
11. Fan PY et al, The effects of short-term treatment with the prostaglandin E1 (PGE1) analog misoprostol on inflammatory mediator production in murine lupus nephritis. Clin Immunol Immunopathol (1995) 75: 125-30.
12. Dejarnatt AC, Grant JA, Alam R, Misoprostol (MPL), a PGE analogue, inhibits the late, but not the immediate cutaneous reaction to dust mite antigens. J Allergy Clin Immunol (1992) 89: 200 (abstract).
13. Hogaboam CM et al, Prostaglandins inhibit the inflammatory mediator release from rat mast cells. Gastroenterology (1993) 104: 122-9
14. Mullins MD, Serafin WE, Murray JJ, Immunomodulatory effects of the stable prostaglandin E analog misoprostol in vivo. J Allergy Clin Immunol (1994) 93: 203 (abstract).
15. Ham EA et al, Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci USA (1989) 80: 4349-53.
16. Alam R et al, Selective inhibition of the cutaneous late but not immediate allergic response to antigens by misoprostol, a PGE analog - results of a double-blind, placebo-controlled randomized study. Am Rev Respir Dis (1993) 148: 1066-70.
17. Wiederkehr JC et al, Immunosuppressive effects of misoprostol: a new prostaglandin E1 analogue. Aust NZ J Surg (1990) 60: 121-4.
18. Pollak R et al, The immunosuppressive properties of new oral prostaglandin E1 analogs. Transplantation (1990) 50: 834-8.
19. Al-Attiyah R, Rosen H, Rook GAW, A model for the investigation of factors influencing hemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations. Clin Exp Immunol (1992) 88: 537-42.
20. Vinogradov AI, Vinogradova NA, Study of prostaglandin E2 antimediator properties and therapeutic efficacy in children suffering from atopic dermatitis. Vestn Dermatol Venerol (1993) N4: 24-8 (in Russian).
21. Willemse T, Atopic skin disease: a review and a reconsideration of diagnostic criteria. J Small Anim Pract (1986) 27: 771-8.
22. Scott DW, Miller WHJ, Griffin CE, Small animal dermatology, 5 edn. W B. Saunders: Philadelphia, 1995, pp 500-18.
23. Murtaugh RJ et al, Use of synthetic prostaglandin E1 (misoprostol) for prevention of aspirin-induced gastroduodenal ulceration in arthritic dogs J Am Vet Med Assoc (1993) 202: 251-6.
24. Johnston SA et al, The effect of misoprostol on aspirin-induced gastroduodenal lesions in dogs. J Vet Intern Med (1995) 9: 32-8.
25. Paradis M, Scott DW, Giroux D, Further investigations on the use of nonsteroidal and steroidal antiinflammatory agents in the management of canine pruritus. J Am Anim Hosp Assoc (1991) 27: 44-8
26. Kapp A, Atopic dermatitis - the skin manifestation of atopy. Clin Exp Allergy (1995) 25: 210-19.
27. Friedmann PS et al, Pathogenesis and management of atopic dermatitis. Clin Exp Allergy (1995) 25: 799-806.
28. Leung DYM, Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol (1995) 96: 302-18
29. Smallwood JI, Malawista SE, Misoprostol stimulates leukocyte cyclic adenosine 3′,5′ monophosphate production and synergizes with colchicine: novel combination of established drugs may boost antiinftammatory potential. J Pharmacol Exp Ther (1994) 269: 1196-204.
30. Chan SC et al, Altered prostaglandin E2 regulation of cytokine production in atopic dermatitis. J Immunol (1993) 151: 3345-52.
31. Frew AJ et al, Immunohistology of human allergic late-phase skin reactions. Skin Pharmacol (1991) 4 (suppl 1): 71-8.
32. Wershil BK et al, Recruitment of neutrophils during IgE-dependent cutaneous late-phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest (1991) 87: 446-53.
33. Weiss JM et al, Prostaglandin E1 inhibits TNFα-induced T cell adhesion to endotheual cells. J Invest Dermatol (1994) 103: 414 (abstract).
34. Rossetti RG, Brathwaite K, Zurier RB, Suppression of acute inflammation with liposome associated prostaglandin E1. Prostaglandins (1994) 48: 187-95.